Table 1. Baseline parameters of patients with ROS1 positive NSCLC.

Patients’ characteristics	n = 70, (%)
Age in years, Median (Range)	52 (26–78)
Gender Male Female	39 (55.70%) 31 (44.30%)
ECOG PS 0–1 2 >2	45 (64.3%) 15 (21.4%) 10 (14.3%)
Comorbidity Yes Hypertension Diabetes mellitus Chronic kidney disease Ischemic heart disease No	21 (30.0%) 14 (20.0%) 12 (17.14%) 3 (4.29%) 2 (8.86%) 49 (70.0%)
Histology Adenocarcinoma	70 (100.0%)
Smoking status Never-smoker Ever-smoker	51 (72.86%) 19 (27.14%)
Family history of malignancy Yes No Not documented	8 (11.43%) 41 (58.57%) 21 (30%)
Baseline AJCC stage I II III IV	0 (0%) 0 (0%) 2 (2.86%) 68 (97.14%)
Initial sites of metastasis Lungs (parenchymal/(pleural deposits and effusion)) Bone Liver CNS Adrenal gland Non-regional lymph node Others	49 (70.0%) (36 (51.4%)/31 (44.3%)) 20 (28.57%) 10 (14.3%) 13 (18.57%) 7 (10.0%) 32 (45.71%) 4 (5.71%)